MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
SYN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Synthetic Biologics (SYN) Ownership - Who owns Synthetic Biologics?

Synthetic Biologics is a late-stage biotechnology company focused on developing gut microbiome therapeutics... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
9605 Medical Center Drive
Phone
+1 301 417-4364
Employees
16
Web
https://www.syntheticbiologics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
16.16M
P/E Ratio
N/A
Total Cash
52.27M
Projected Growth
N/A
Total Debt
1.7M
Revenue
N/A
Risk (Beta)
1.07
Dividend Yield
N/A
Total Cash/Share
3.30
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for SYN
A.I. Advisor
published General Information

General Information

a manufacturer of drugs for the treatment of neurological diseases

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
9605 Medical Center Drive
Phone
+1 301 417-4364
Employees
16
Web
https://www.syntheticbiologics.com